Nanobiotechnological modification of hemoglobin and enzymes from this laboratory

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 10, 2008, Pages 1435-1440

  Chang, Thomas Ming Swi ^a  

^a Faculty of Medicine   (Canada)

Author keywords

Blood substitutes; Catalase; Fibrinogen; Hemoglobin; Melanoma; Nanobiotechnology; Nanomedicine; Polyhemoglobin; Superoxide dismutase; Tyrosinase

Indexed keywords

CATALASE; HEMOGLOBIN; METHEMOGLOBIN; POLYHEMOGLOBIN; POLYHEMOGLOBIN TYROSINASE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; SALICYLIC ACID; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CROSS LINKING; ENZYME MODIFICATION; ERYTHROCYTE; HUMAN; HYDROXYLATION; IRON KINETICS; ISCHEMIA; LIPID MEMBRANE; LIPID PEROXIDATION; LIPID VESICLE; MELANOMA; NANOBIOTECHNOLOGY; NONHUMAN; OXIDATION; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REPERFUSION INJURY; SCREENING TEST; SKIN CANCER; THROMBOCYTE;

ANIMALS; BLOOD SUBSTITUTES; CATALASE; COMPLEMENT ACTIVATION; CROSS-LINKING REAGENTS; FIBRINOGEN; HEMOGLOBIN A; HEMOGLOBINS; HUMANS; MONONUCLEAR PHAGOCYTE SYSTEM; NANOTECHNOLOGY; OXYHEMOGLOBINS; SUPEROXIDE DISMUTASE;

EID: 52049126812     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.05.006     Document Type: Article

References (28)

1. Chang T.M.S. Semipermeable microcapsules. Science 146 3643 (1964) 524
2. Chang T.M.S. Artificial Cells. Monograph (1972), Charles C. Thomas, Springfield, IL. http://www.artcell.mcgill.ca (Full text available at www.artcell.mcgill.ca)
3. Chang T.M.S. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem. Biophys. Res. Common. 44 6 (1971) 1531-1536
4. Chang T.M.S. Monograph on "ARTIFICIAL CELLS: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy" (2007), World Science Publisher 452 pages
5. Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.1 (1997). http://www.artcell.mcgill.ca Basel Karger, 1997 (Full text and updates available for free online viewing at www.artcell.mcgill.ca)
6. Perutz M.F. Myoglobin and Hb: role of distal residues in reactions with haem ligands. Trends Biochem. Sci. 14 (1989) 42-44
7. Gould S.A., et al. The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 195 (2002) 445-452
8. Pearce L.B., Gawryl M.S., Rentko V.T., Moon-Massat P.F., and Rausch C.W. HBOC-201 (Hb Glutamer-250 (Bovine), hemopure): clinical studies. In: Winslow R. (Ed). Blood Substitutes (2006), Academic Press, San Diego 437-450
9. D'Agnillo F., and Chang T.M.S. PolyHb-superoxide dismutase. Catalase as a blood substitute with antioxidant properties. Nat. Biotechnol. 16 7 (1998) 667-671
10. Alayash A.I. Oxygen therapeutics: can we tame Hb. Nat. Rev. Drug Discov. 3 (2004) 152-159
11. Powanda D., and Chang T.M.S. Cross-linked polyHb-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif. Cells Blood Substit. Immobil. Biotechnol., Int. J. 30 (2002) 25-42
12. D'Agnillo F., and Chang T.M.S. Cross-linked hemoglobin-superoxide dismutasecatalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release. Biomater. Artif. Cells Immobil. Biotechnol. 21 (1993) 609-622
13. Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal. Biochem. 40 (1971) 450-458
14. Chang TMS. (1957) Hb corpuscles. Report of a research project of B.Sc. Honours Physiology, McGill University, 1-25, 1957. Medical Library, McGill University (also reprinted in Chang (TMS) J. Biomaterials, Artificial Cells and Artificial Organs 16:1-9, 1988 and also in Chang TMS (2007) monograph on Artificial Cells, World Scientific Publisher, Singapore).
15. Djordjevich L., and Miller I.F. Synthetic erythrocytes from lipid encapsulated Hb. Exp. Hematol. 8 (1980) 584
16. Philips W.T., Klpper R.W., Awasthi V.D., Rudolph A.S., Cliff R., Kwasiborski V.V., and Goins B.A. Polyethylene glyco-modified liposome-encapsulated Hb: a long circulating red cell substitute. J. Pharm. Exp. Ther. 288 (1999) 665-670
17. In: Kobayashi K., Tsuchida E., and Horinouchi H. (Eds). Artificial Oxygen Carriers (2005), Spring-Verlag Publisher
18. Sakai H., Masada Y., Takeoka S., and Tsuchida E. Characteristics of bovine Hb as a potential source of Hb vesicles for an artificial oxygen carrier. J. Biochem. 131 (2002) 611-617
19. Chang T.M.S. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J. Bioeng. 1 (1976) 25-32
20. Yu W.P., and Chang T.M.S. Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes: a preliminary report. Artif. Cells Blood Substit. Immobil. Biotechnol., Int. J. 22 (1994) 889-894
21. Yu W.P., and Chang T.M.S. Submicron biodegradable polymer membrane Hb nanocapsules as potential blood substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol., Int. J. 24 (1996) 169-184
22. Chang T.M.S., and Yu W.P. Nanoencapsulation of Hb and RBC enzymes based on nanotechnology and biodegradable polymer. In: Chang T.M.S. (Ed). Blood Substitutes: Principles, Methods, Products and Clinical Trials vol. 2 (1998), Karger, Basel 216-231
23. Chang T.M.S., Powanda D., and Yu W.P. Ultrathin polyethylene-glycol-polylactide copolymer membrane nanocapsules containing polymerized Hb and enzymes as nano-dimension RBC substitutes. Artif. Cells Blood Substit. Immobil. Biotechnol., Int. J. 31 (2003) 231-248
24. Chang T.M.S. Artificial cells with cofactor regenerating multienzyme systems. Methods in Enzymology 112 (1985) 195-203
25. Wong N., and Chang T.M.S. Polyhemoglobin-fibrinogen: a novel blood substitutes with platelet-like activity for extreme hemodilution. Artif. Cells Blood Substitut. Biotechnol. 35 (2007) 481-489
26. Yu B.L., and Chang T.M.S. In vitro and in vivo effects of polyHb-tyrosinase on murine B16F10 melanoma. Melanoma Res. 14 (2004) 197-202 1
27. Bucci E., Matheson B., Kwansa H., and Koehler R.C. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion. Biotechnol. 35 1 (2007) 11-18
28. Tarasov E., Blaszak M.M., LaMarre J.M., and Olsen K.W. Synthesis of a hemoglobin polymer containing antioxidant enzymes using complementary chemistry of maleimides and sulfhydryls. Artif. Cells Blood Substitut. Biotechnol. 35 1 (2007) 31-43